Text Education About Cardiovascular Health and HIV (TEACH-HIV)
2 other identifiers
interventional
260
1 country
2
Brief Summary
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Mar 2023
Typical duration for not_applicable hiv
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedStudy Start
First participant enrolled
March 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedJune 8, 2025
June 1, 2025
2.7 years
November 18, 2022
June 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of participants with controlled blood pressure
Proportion of participants with blood pressure \< 130/80 mmHg as recorded in the electronic health record (EHR).
6 months
Secondary Outcomes (11)
Number of cardiovascular risk factors controlled
6 months
Self-perceived cardiovascular risk
6 months
Systolic blood pressure
6 months
Cholesterol
6 months
Physical activity
6 months
- +6 more secondary outcomes
Study Arms (2)
Intervention Arm
EXPERIMENTALThe intervention arm will receive education about HIV and heart disease risk via mobile phone text messages for up to 6 months. They will receive the text messages 3-5 times per week. The messages will include information about HIV and risk of heart disease and information about how to reduce heart disease risk. The intervention arm will also receive brief monthly surveys via a digital research platform.
Control Arm
NO INTERVENTIONThe control arm will not receive the educational text messages. They will receive brief monthly surveys via a digital research platform.
Interventions
Education via mobile phone text messages for up to 6 months.
Eligibility Criteria
You may qualify if:
- HIV positive
- At least 40 years of age
- English-speaking
You may not qualify if:
- Existing clinical atherosclerotic cardiovascular disease (ASCVD)
- Pregnant
- Unwilling/unable to provide informed consent
- Does not own a smartphone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
University of California San Francisco
San Francisco, California, 94115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan McLaughlin, MD, MPH
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2022
First Posted
December 8, 2022
Study Start
March 12, 2023
Primary Completion
December 1, 2025
Study Completion
July 1, 2026
Last Updated
June 8, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share